User menu

Apelin beyond kidney failure and hyponatremia: a useful biomarker for cancer disease progression evaluation

Bibliographic reference Lacquaniti, Antonio ; Altavilla, Giuseppe ; Picone, Antonio ; Donato, Valentina ; Chirico, Valeria ; et. al. Apelin beyond kidney failure and hyponatremia: a useful biomarker for cancer disease progression evaluation. In: Clinical and Experimental Medicine (Online), Vol. 15, no.1, p. 97-105 (2014)
Permanent URL
  1. Maguire J. J., Kleinz M. J., Pitkin S. L., Davenport A. P., [Pyr1]Apelin-13 Identified as the Predominant Apelin Isoform in the Human Heart: Vasoactive Mechanisms and Inotropic Action in Disease, 10.1161/hypertensionaha.109.134619
  2. Galanth Cecile, Hus-Citharel Annette, Li Bo, Llorens-Cortes Catherine, Apelin in the Control of Body Fluid Homeostasis and Cardiovascular Functions, 10.2174/138161212799277770
  3. Masri B, Morin N, Cornu M et al (2004) Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. FASEB J 18:1909–1911
  4. Kasai Atsushi, Shintani Norihito, Oda Maki, Kakuda Michiya, Hashimoto Hitoshi, Matsuda Toshio, Hinuma Shuji, Baba Akemichi, Apelin is a novel angiogenic factor in retinal endothelial cells, 10.1016/j.bbrc.2004.10.042
  5. Kälin Roland E., Kretz Martin P., Meyer Andrea M., Kispert Andreas, Heppner Frank L., Brändli André W., Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis, 10.1016/j.ydbio.2007.03.004
  6. Ronkainen V.-P., Ronkainen J. J., Hanninen S. L., Leskinen H., Ruas J. L., Pereira T., Poellinger L., Vuolteenaho O., Tavi P., Hypoxia inducible factor regulates the cardiac expression and secretion of apelin, 10.1096/fj.06-7294com
  7. O'Carroll A.-M., Lolait S. J., Regulation of Rat APJ Receptor Messenger Ribonucleic Acid Expression in Magnocellular Neurones of the Paraventricular and Supraopric Nuclei by Osmotic Stimuli : Osmotic stimulation of APJ receptor mRNA in magnocellular neurones, 10.1046/j.1365-2826.2003.01044.x
  8. Taheri Shahrad, Murphy Kevin, Cohen Mark, Sujkovic Elizabeth, Kennedy Adam, Dhillo Waljit, Dakin Catherine, Sajedi Arshia, Ghatei Mohammad, Bloom Stephen, The Effects of Centrally Administered Apelin-13 on Food Intake, Water Intake and Pituitary Hormone Release in Rats, 10.1006/bbrc.2002.6575
  9. Llorens-Cortes Catherine, Moos Francoise, Apelin and Vasopressin: Two Work Better than One : Neuroendocrinology Briefing 43, 10.1111/j.1365-2826.2012.02316.x
  10. Lacquaniti A (2012) Hyponatremia in hospitalized patients: an underestimated problem. G Ital Nefrol 29:261
  11. Jeppesen A N, Jensen H K, Donskov F, Marcussen N, von der Maase H, Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma, 10.1038/sj.bjc.6605563
  12. Lameire Norbert, Van Biesen Wim, Vanholder Raymond, Electrolyte Disturbances and Acute Kidney Injury in Patients With Cancer, 10.1016/j.semnephrol.2010.09.002
  13. Castillo J. J., Vincent M., Justice E., Diagnosis and Management of Hyponatremia in Cancer Patients, 10.1634/theoncologist.2011-0400
  14. Thompson Chris, Hoorn Ewout J., 1 Hyponatraemia: an overview of frequency, clinical presentation and complications, 10.1016/s1521-690x(12)00019-x
  15. Edge SB, Byrd DR, Compton CC et al (2010) American Joint Committee on Cancer staging manual, 7th edn. Springer, New York, NY
  16. Therasse Patrick, Arbuck Susan G., Eisenhauer Elizabeth A., Wanders Jantien, Kaplan Richard S., Rubinstein Larry, Verweij Jaap, Van Glabbeke Martine, van Oosterom Allan T., Christian Michaele C., Gwyther Steve G., New Guidelines to Evaluate the Response to Treatment in Solid Tumors, 10.1093/jnci/92.3.205
  17. Hermes Andreas, Waschki Benjamin, Reck Martin, Hyponatremia as prognostic factor in small cell lung cancer – A retrospective single institution analysis, 10.1016/j.rmed.2012.02.010
  18. Doshi Simit M., Shah Pankaj, Lei Xiudong, Lahoti Amit, Salahudeen Abdulla K., Hyponatremia in Hospitalized Cancer Patients and Its Impact on Clinical Outcomes, 10.1053/j.ajkd.2011.08.029
  19. Gandhi Leena, Johnson Bruce E., Paraneoplastic Syndromes Associated With Small Cell Lung Cancer, 10.6004/jnccn.2006.0052
  20. Berta Judit, Kenessey Istvan, Dobos Judit, Tovari Jozsef, Klepetko Walter, Jan Ankersmit Hendrik, Hegedus Balazs, Renyi-Vamos Ferenc, Varga Janos, Lorincz Zsolt, Paku Sandor, Ostoros Gyula, Rozsas Anita, Timar Jozsef, Dome Balazs, Apelin Expression in Human Non-small Cell Lung Cancer: Role in Angiogenesis and Prognosis, 10.1097/jto.0b013e3181e2c1ff
  21. Heo Kyun, Kim Yun Hee, Sung Ho Jin, Li Hai Ying, Yoo Chong Woo, Kim Joo Young, Park Joo Yong, Lee Ui Lyong, Nam Byung Ho, Kim Eun Ok, Kim So Young, Lee Seung Hoon, Park Jong Bae, Choi Sung Weon, Hypoxia-induced up-regulation of apelin is associated with a poor prognosis in oral squamous cell carcinoma patients, 10.1016/j.oraloncology.2011.12.015
  22. Eyries M., Siegfried G., Ciumas M., Montagne K., Agrapart M., Lebrin F., Soubrier F., Hypoxia-Induced Apelin Expression Regulates Endothelial Cell Proliferation and Regenerative Angiogenesis, 10.1161/circresaha.108.179333
  23. Kidoya H, Kunii N, Naito H, Muramatsu F, Okamoto Y, Nakayama T, Takakura N, The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy, 10.1038/onc.2011.489
  24. Sorli S. Caroline, van den Berghe Loïc, Masri Bernard, Knibiehler Bernard, Audigier Yves, Therapeutic potential of interfering with apelin signalling, 10.1016/j.drudis.2006.10.011
  25. Sorli S C, Le Gonidec S, Knibiehler B, Audigier Y, Apelin is a potent activator of tumour neoangiogenesis, 10.1038/sj.onc.1210573
  26. Iwanaga Yoshitaka, Kihara Yasuki, Takenaka Hiroyuki, Kita Toru, Down-regulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin II–angiotensin type 1 receptor system, 10.1016/j.yjmcc.2006.07.004
  27. Kazemi-Bajestani SM, Patel VB, Wang W et al (2012) Targeting the ACE2 and apelin pathways are novel therapies for heart failure: opportunities and challenges. Cardiol Res Pract 2012:823193
  28. Feng Y, Ni L, Wan H et al (2011) Over expression of ACE2 produces antitumor effects via inhibition of angiogenesis and tumor cell invasion in vivo and in vitro. Oncol Rep 26:1157–1164
  29. Yasumatsu Ryuji, Nakashima Torahiko, Masuda Muneyuki, Ito Aya, Kuratomi Yuichiro, Nakagawa Takashi, Komune Shizuo, Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells, 10.1007/s00432-004-0582-7
  30. Larrinaga Gorka, Pérez Itxaro, Sanz Begoña, Blanco Lorena, López Jose I., Cándenas M. Luz, Pinto Francisco M., Gil Javier, Irazusta Jon, Varona Adolfo, Angiotensin-converting enzymes (ACE and ACE2) are downregulated in renal tumors, 10.1016/j.regpep.2010.07.170
  31. Feng Y, Wan H, Liu J et al (2010) The angiotensin-converting enzyme 2 in tumor growth and tumor-associated angiogenesis in non-small cell lung cancer. Oncol Rep 23:941–948
  32. Lv Shuang-Yu, Yang Yan-Jie, Qin Yao-Jun, Mo Jia-Run, Wang Ning-Bo, Wang Yi-Jing, Chen Qiang, Central apelin-13 inhibits food intake via the CRF receptor in mice, 10.1016/j.peptides.2011.11.011